Product Details for ANDA 091220
GLIMEPIRIDE (GLIMEPIRIDE)
1MG
Marketing Status: Prescription
2MG
Marketing Status: Prescription
3MG
Marketing Status: Prescription
4MG
Marketing Status: Prescription
6MG
Marketing Status: Prescription
8MG
Marketing Status: Prescription
1MG
Marketing Status: Prescription
Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 001
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
GLIMEPIRIDE (GLIMEPIRIDE)
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 001
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
2MG
Marketing Status: Prescription
Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 002
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
GLIMEPIRIDE (GLIMEPIRIDE)
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 002
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
3MG
Marketing Status: Prescription
Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 3MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091220
Product Number: 003
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
GLIMEPIRIDE (GLIMEPIRIDE)
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 3MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091220
Product Number: 003
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
4MG
Marketing Status: Prescription
Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 004
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
GLIMEPIRIDE (GLIMEPIRIDE)
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 004
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
6MG
Marketing Status: Prescription
Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 6MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091220
Product Number: 005
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
GLIMEPIRIDE (GLIMEPIRIDE)
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 6MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091220
Product Number: 005
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
8MG
Marketing Status: Prescription
Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 8MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 006
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 8MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 006
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status: Prescription
Patent and Exclusivity Information